95-16207. Crabmeat; Amendment of Common or Usual Name Regulation  

  • [Federal Register Volume 60, Number 127 (Monday, July 3, 1995)]
    [Rules and Regulations]
    [Pages 34459-34460]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-16207]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 102
    
    [Docket No. 92P-0476]
    
    
    Crabmeat; Amendment of Common or Usual Name Regulation
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the common 
    or usual name regulation for crabmeat by adding ``Brown King crabmeat'' 
    as the common or usual name for the species Lithodes aequispina. This 
    amendment is in response to a citizen petition submitted by the Alaska 
    Seafood Marketing Institute (ASMI).
    
    Effective Date: August 2, 1995.
    
    FOR FURTHER INFORMATION CONTACT: Spring C. Randolph, Office of Seafood 
    (HFS-416), Food and Drug Administration, 200 C St. SW., Washington, DC 
    20204, 202-418-3160.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        In the Federal Register of July 15, 1994 (59 FR 36103), FDA 
    proposed to amend the common or usual name provisions for crabmeat, 
    (Sec. 102.50 (21 CFR 102.50)), to provide that the common or usual name 
    of crabmeat derived from the species L. aequispina is ``Brown King 
    crabmeat.'' The proposal was issued in response to a citizen petition 
    submitted by ASMI. Previous to this rulemaking, Sec. 102.50 provided 
    that only the crabmeat from three species of the genus Paralithodes may 
    be labeled as ``King crabmeat.'' Interested persons were given until 
    September 13, 1994, to submit comments.
    
    II. Comments
    
        FDA received one comment in response to the proposed amendment. 
    That comment, submitted by a trade association supported the proposal 
    and stated that establishing ``Brown King crabmeat'' as the common or 
    usual name for the crabmeat will benefit 
    
    [[Page 34460]]
    consumers by providing a consistent statement of identity for L. 
    aequispina.
    
    III. Conclusion
    
         For reasons stated in the proposal and in the absence of comments 
    objecting to the proposed amendment, FDA concludes that it is 
    appropriate to revise Sec. 102.50 by adding ``Brown King crabmeat'' as 
    the common or usual name for the meat of L. aequispina. FDA notes that 
    under section 403(b) and (i)(1) of the Federal Food, Drug, and Cosmetic 
    Act (the act) (21 U.S.C. 343(b) and (i)(1)) and Sec. 101.3 (b) (1) (21 
    CFR 101.3 (b)(1)), a food with a common or usual name established by 
    regulation is misbranded if it is not identified by that name.
        FDA is also making a minor revision in Sec. 102.50, that is 
    separate from this rulemaking. After publication of the proposal, the 
    agency became aware that a change had been made in the accepted 
    scientific designation for the species listed therein as Paralithodes 
    camtschatica, and that it had not revised the regulation to reflect 
    this change. Therefore, to maintain consistency with currently accepted 
    scientific nomenclature, FDA is changing the spelling of the name of 
    this species in Sec. 102.50, to read Paralithodes camtschaticus (see 
    American Fisheries Society Special Publication 17, ``Common and 
    Scientific Names of Aquatic Invertebrates from the United States and 
    Canada: Decapod Crustaceans'').
    
    IV. Environmental Impact
    
        The agency has previously considered the environmental effects of 
    this rule as announced in the proposed rule of July 15, 1994 (59 FR 
    36103). No new information or comments have been received that would 
    affect the agency's previous determination that there is no significant 
    impact on the human environment and that an environmental impact 
    statement is not required.
    
    V. Analysis of Impacts
    
        FDA has examined the impacts of the final rule under Executive 
    Order 12866 and the Regulatory Flexibility Act (Pub. L. 96-354). 
    Executive Order 12866 directs agencies to assess all costs and benefits 
    of available regulatory alternatives and, when regulation is necessary, 
    to select regulatory approaches that maximize net benefits (including 
    potential economic, environmental, public health and safety, and other 
    advantages; distributive impacts; and equity). The agency believes that 
    this final rule is consistent with the regulatory philosophy and 
    principles identified in the Executive Order. In addition, the final 
    rule is not a significant regulatory action as defined by the Executive 
    Order and so is not subject to review under the Executive Order.
        The Regulatory Flexibility Act requires agencies to analyze 
    regulatory options that would minimize any significant impact of a rule 
    on small entities. Because FDA did not receive any comments or new 
    information on this issue, the agency certifies that the final rule 
    will not have a significant economic impact on a substantial number of 
    small entities. Therefore, under the Regulatory Flexibility Act, no 
    further analysis is required.
    
    List of subjects in 21 CFR Part 102
    
        Beverages, Food grades and standards, Food labeling, Frozen foods, 
    Oils and fats, Onions, Potatoes, Seafood.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    102 is amended as follows:
    
    PART 102--COMMON OR USUAL NAME FOR NONSTANDARDIZED FOODS
    
         1. The authority citation for 21 CFR part 102 continues to read as 
    follows:
    
        Authority: Secs. 201, 403, 701 of the Federal Food, Drug, 
    andCosmetic Act (21 U.S.C 321, 343, 371).
    
        2. Section 102.50 is amended by revising the table to read as 
    follows:
    
    
    Sec. 102.50  Crabmeat.
    
     * * * * *
    
                                                                            
    ------------------------------------------------------------------------
          Scientific name of crab          Common or usual name of crabmeat 
    ------------------------------------------------------------------------
    Chionoecetes opilio,                 Snow crabmeat.                     
    Chionoecetes tanneri,                                                   
    Chionoecetes bairdii, and                                               
    Chionoecetes angulatus,                                                 
    Erimacrus isenbeckii                 Korean variety crabmeat or Kegani  
                                          crabmeat.                         
    Lithodes aequispina                  Brown King crabmeat.               
    Paralithodes brevipes                King crabmeat or Hanasaki crabmeat.
    Paralithodes camtschaticus           King crabmeat. and Paralithodes    
                                          Platypus.                         
    ------------------------------------------------------------------------
    
    
        Dated: June 26, 1995.
    William B. Schultz,
    Deputy Commissioner for Policy.
    [FR Doc. 95-16207 Filed 6-30-95; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
8/2/1995
Published:
07/03/1995
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
95-16207
Dates:
August 2, 1995.
Pages:
34459-34460 (2 pages)
Docket Numbers:
Docket No. 92P-0476
PDF File:
95-16207.pdf
CFR: (1)
21 CFR 102.50